These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16799659)

  • 1. Ru106 brachytherapy for management of choroidal melanoma: do we need to adjust total dose according to the new NIST calibration measurement?
    Lotayef MM; Othman IS; Shelil AE; Kerima H
    J Egypt Natl Canc Inst; 2005 Sep; 17(3):211-7. PubMed ID: 16799659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques.
    Kaulich TW; Zurheide J; Haug T; Budach W; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2004 Jun; 180(6):358-64. PubMed ID: 15175870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
    Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
    Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
    Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
    Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.
    Marinkovic M; Horeweg N; Fiocco M; Peters FP; Sommers LW; Laman MS; Bleeker JC; Ketelaars M; Luyten GP; Creutzberg CL
    Eur J Cancer; 2016 Nov; 68():106-113. PubMed ID: 27741435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma.
    Filì M; Trocme E; Herrspiegel C; Seregard S; Stålhammar G
    Br J Ophthalmol; 2021 Jan; 105(1):57-62. PubMed ID: 32430342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.
    Hegde JV; McCannel TA; McCannel CA; Lamb J; Wang PC; Veruttipong D; Almanzor R; Demanes DJ; Kamrava M
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1843-1850. PubMed ID: 28597076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of choroidal melanomas less than 10 mm in largest basal diameter with a 10-mm ruthenium plaque.
    Salkola S; Heikkonen J; Eskelin S; Kivelä T
    Retina; 2014 Oct; 34(10):2110-20. PubMed ID: 24978431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma.
    AlMahmoud T; Quinlan-Davidson S; Pond GR; Deschênes J
    Middle East Afr J Ophthalmol; 2018; 25(2):103-107. PubMed ID: 30122856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.
    Russo A; Laguardia M; Damato B
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1533-40. PubMed ID: 22354369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone.
    Yarovoy AA; Magaramov DA; Bulgakova ES
    Brachytherapy; 2012; 11(3):224-9. PubMed ID: 22104351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
    Semenova E; Finger PT
    JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma.
    O'Day RFJ; Roelofs KA; Negretti GS; Hay G; Arora AK; Stoker I; Damato BE; Sagoo MS; Cohen VML
    Eye (Lond); 2023 Apr; 37(5):959-965. PubMed ID: 35140328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does escalation of the apical dose change treatment outcome in beta-radiation of posterior choroidal melanomas with 106Ru plaques?
    Hermann RM; Pradier O; Lauritzen K; Ott M; Schmidberger H; Hess CF
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1360-6. PubMed ID: 11955750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106.
    Sallet G; Amoaku WM; Lafaut BA; Van Liefferinge B; De Laey JJ
    Bull Soc Belge Ophtalmol; 1996; 263():27-37. PubMed ID: 9396191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
    Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.